What is LIC's current stake in Sun Pharma?

LIC's stake in Sun Pharma is currently over 5%, specifically 5.004% as of January 14.

How much did Sun Pharma invest in R&D?

Sun Pharma invested ₹1685.5 crore in research and development, which is 6% of its total sales.

Which markets are driving Sun Pharma's growth?

Sun Pharma's growth is led by India, emerging markets, and the rest of the world, with US innovative medicine sales surpassing generics.

Home / Business and Economy / LIC Boosts Sun Pharma Stake Past 5%

LIC Boosts Sun Pharma Stake Past 5%

14 Jan

•

Summary

LIC increased its Sun Pharma holding to over 5% on January 14.
LIC acquired 2,02,500 additional shares on January 13.
Sun Pharma invested ₹1685.5 crore in research and development.

Life Insurance Corporation of India (LIC) has increased its stake in Sun Pharma, crossing the 5% ownership mark. As of January 14, LIC's shareholding in the prominent pharmaceutical company now stands at 5.004%, up from 4.996%. This acquisition of 2,02,500 shares on January 13 underscores LIC's significant presence as a major institutional investor.

Sun Pharma's stock has demonstrated strong long-term performance, rallying significantly over the past five and ten years. The company's dedication to innovation is further evidenced by its substantial investment of ₹1685.5 crore in research and development, accounting for 6% of its total sales.